About US
Contact us
-
J&J's Zytiga gets early challenge from Medivation's new pillAstellas Pharma and Medivation ($MDVN) won FDA approval for their prostate cancer treatment Xtandi three months ahead of schedule. That's welcome news for them--but perhaps not so welcome for compet2012/9/5
-
Pfizer, Boehringer drug delays asthma attacksA lung drug developed by Boehringer Ingelheim and Pfizer helped delay severe asthma attacks in adults during two last-stage trials, according to data presented at the 2012 European Respiratory Society2012/9/4
-
Roche drug may provide lifeline to tamoxifen-resistant breast cancer patientsScientists in the US have demonstrated how Roche's drug Erivedge (vismodegib) could act as a targeted therapy for breast cancer. A study conducted by researchers at the Ohio State University Comprehe2012/9/4
-
.Lilly pulls schizophrenia treatment after Phase III failureEli Lilly's experimental schizophrenia treatment pomaglumetad methionil has suffered a failure in a Phase III study, forcing the company to pull the drug from further development. The drug, also know2012/9/3
-
Roche drug may provide lifeline to tamoxifen-resistant breast cancer patientsScientists in the US have demonstrated how Roche's drug Erivedge (vismodegib) could act as a targeted therapy for breast cancer. A study conducted by researchers at the Ohio State University Comprehe2012/9/3
-
J&J to pay states $181M to resolve Risperdal casesIn what is probably a prelude to the much larger settlement that Johnson & Johnson ($JNJ) has indicated it has hammered out with federal authorities, the company said today that it has reached a s2012/8/31
-
FDA flags cataract risk in kids using Vertex's KalydecoVertex Pharmaceuticals ($VRTX) has hit an unexpected snag with itscystic fibrosispillKalydeco. The FDA is raising questions about a potential risk of cataracts in children using the drug, and asked th2012/8/31
-
New method simplifies pharmaceutical production of proteinsEngineering researchers at the University of Arkansas have developed a method to simplify the pharmaceutical production of proteins used in drugs that treat a variety of diseases and health conditions2012/8/30
-
Voters need more information on free trade agreement that could impact drug pricesIn anopinion piecein the Guardian's "Comment is Free" blog, Dean Baker, co-director of the Center for Economic and Policy Research, discusses potential policies contained within the "Trans-Pacific Par2012/8/30
-
AstraZeneca entices Roche exec to take on CEO challengeAstraZeneca ($AZN) turned heads today with an unexpectedly intriguing CEO choice: Roche's ($RHHBY) Pascal Soriot, who's been the Swiss drugmaker's COO and pharma chief since 2010. Within hours, Sori2012/8/29